Skip to content

Clinical trials

Mental Disorders trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Finland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20111
20121
20131
20181
20231
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Pfizer2
University of Eastern Finland2
H. Lundbeck A/S1
Hoffmann-La Roche1
Kuopio University Hospital1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Oulu University Hospital1
Sanofi1
Toni Salikka1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders14
Alzheimer Disease4
Dementia4
Nervous System Diseases4
Brain Diseases3
Central Nervous System Diseases3
Anxiety Disorders2
Depressive Disorder2
Agnosia1
Alcohol-Related Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.